Madhavan V. Pillai MD
Professor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ
Join to View Full Profile
925 Chestnut StSte 320APhiladelphia, PA 19107
Phone+1 215-955-8874
Fax+1 215-955-2340
Dr. Pillai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 1979 - 1982
University of Kerala Medical CollegeClass of 1966
Certifications & Licensure
TX State Medical License 2014 - 2026
PA State Medical License 2010 - 2024
ID State Medical License 2016 - 2020
VA State Medical License 1980 - 2014
DC State Medical License 1989 - 2002
MD State Medical License 1991 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- 3 citationsGastrointestinal Stromal Tumors: A Review.Aakanksha Asija, Alex V. Mejia, Anthony Prestipino, Madhavan V. Pillai
American Journal of Therapeutics. 2016-03-01 - 29 citationsThe efficacy and safety of panitumumab administered concomitantly with FOLFIRI or Irinotecan in second-line therapy for metastatic colorectal cancer: the secondary ana...Edith P. Mitchell, Bilal Piperdi, Mario E. Lacouture, Heather Shearer, Nicholas Iannotti
Clinical Colorectal Cancer. 2011-12-01 - 50 citationsA randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgras...J. Randolph Hecht, Madhavan V. Pillai, Russell Gollard, William Heim, Forrest Swan
Clinical Colorectal Cancer. 2010-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
